Quick Answer
ACTUATE THERAPEUTICS, INC. reported Stockholders Equity of $7.92 million for the year ending 2025.
- ACTUATE THERAPEUTICS, INC. showed an increase of +7,505.6% in Stockholders Equity from 2024 to 2025.
- This data is from ACTUATE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: -$80.50 million | Q2 2023: -$85.95 million | Q3 2023: -$92.14 million | Q1 2024: -$107.77 million | Q2 2024: -$114.26 million | Q3 2024: $5.36 million | Q1 2025: -$5.09 million | Q2 2025: -$2.65 million | Q3 2025: $10.94 million.
- Over the full 4 years of available data (2022 to 2025), ACTUATE THERAPEUTICS, INC.'s Stockholders Equity has grown by 110.5%.
- Historical annual values: Fiscal year 2025: $7.92 million | Fiscal year 2024: $104.2 thousand | Fiscal year 2023: -$99.63 million | Fiscal year 2022: -$75.31 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: